Heritage Global Inc. (HGBL) stock intrinsic value fair value estimate & owner earnings analysis

Heritage Global is a small San Diego company that helps other businesses dispose of assets. It runs industrial auctions and liquidations (Heritage Global Partners), refurbishes and resells laboratory equipment (American Laboratory Trading), and brokers portfolios of charged-off consumer receivables for banks (NLEX). In January 2026 it bought DebtX, a commercial loan-sale marketplace, for about $8.5 million in cash, and in July 2026 it added Boston Note, a broker of seller-financed real estate notes, on terms it has not disclosed. Most of its fee businesses need little capital, but results swing with how many large plant closures, bankruptcies and loan-portfolio sales come to market in a given year. What changed since our last look: the company's specialty lending arm, Heritage Global Capital, has now been formally written down and is being wound down. In the June 2026 quarter the company recorded an $18.2 million impairment of its lending joint ventures and a $3.5 million credit-loss charge, after its largest borrower, in default since June 2024, deteriorated further. The lending investments fell from $21.1 million at year-end to $1.2 million, and the remaining loans to $3.9 million. That loss is real money: roughly a third of shareholders' equity, which fell from $67.0 million to $51.9 million. It is now largely behind the business, but it is the clearest evidence of how management allocates capital, and we weigh it accordingly. How we measure earnings. We start from operating cash flow, strip out working-capital swings (including cash held for auction sellers), subtract stock compensation and only the routine level of equipment spending, and add the cash the company actually receives from its auction joint ventures, which the cash-flow statement shows separately. We excluded the $7.4 million purchase of the Nancy Ridge Drive headquarters and warehouse in 2025 as a one-time decision to own rather than lease. On that basis owner earnings per share were $0.06 in 2017, $0.20 in 2018, $0.16 in 2019, $0.23 in 2020, $0.08 in 2021, $0.31 in 2022, $0.36 in 2023, $0.23 in 2024 and $0.13 in 2025. Two adjustments matter for the future: 2023 and 2024 each included about $2 million of lending profit that no longer exists, and past cash taxes were held down by loss carryforwards. The lending loss creates new tax deductions worth a few million dollars, which we count once, as an asset, rather than in the earnings level. The earnings level. Measured across the 2019-2025 cycle and excluding the lending unit, the ongoing businesses have earned roughly $3 million pre-tax in lean years (2019, 2021) and $7 to $12 million in strong ones (2022 to 2024), with 2025 at about $5.5 million. We use about $5.6 million before interest and tax as normal, roughly 2025's level, and add nothing for DebtX or Boston Note beyond that. DebtX lost $0.5 million in its first half under Heritage ownership, and neither acquisition has a record yet in these hands. That level holds even though the first half of 2026 was weak: the ongoing businesses earned about $1.8 million before the write-downs, against $3.6 million a year earlier. Owner earnings fell about 41% in 2025, so the base case starts 2026 lower, at about $3.3 million, and recovers to the normal level only by 2028. That is a return to a level the business has already reached, not new growth. We credit no growth beyond it. Management talks about a larger auction pipeline and acquisition synergies, but none of that is contracted. The cases. Base: $3.3 million pre-tax in 2026, $4.5 million in 2027, then $5.6 million a year through 2035, taxed at about 26%. After that it fades to zero over ten years, because the moat is relationships and people, not a structural asset. That business is worth about $37 million. Add about $4.5 million of cash beyond seller funds and working needs, about $3 million recovered from the run-off loans and joint ventures, and about $6 million of tax-loss value. Subtract the $4.1 million mortgage, a ten-year fixed loan from C3bank at 6.5% that needs no adjustment. That leaves about $47 million, or $1.34 per share. Bear: the industry's own record of deal droughts, repeating the 2019 and 2021 pattern but deeper. Debt-sale and auction volume dries up for two years, bringing pre-tax profit down to $0.5 to $1.0 million in 2027-2028 as roughly $5 million of corporate overhead absorbs thin segment profit, before recovering only to about $3 million a year. The run-off book returns $1 million and tax assets $3 million. That is a business worth about $18 million, owing $4.1 million, or $0.64 per share. Even in this case the mortgage is small against cash, so the company can carry its debt. Bull: the 2022-2024 conditions return and DebtX and Boston Note add modestly, reaching about $7.5 million a year, with the run-off book largely collected. That is worth about $73 million, or $2.09 per share. What could make this wrong. On the downside, another capital-allocation error of the lending kind. The company's habit of putting its own money into principal deals and partnerships is the risk no case fully models, and it has just cost about $20 million. On the upside, DebtX could prove to be a durable, growing fee stream. Boston Note's price and the cash spent on it after June 30 are not yet disclosed, so the cash figure above may be somewhat overstated. Margin-of-safety price. Our confidence in the earnings level is moderate. Seven years of records show the ongoing businesses swing between about $3 million and $12 million pre-tax, and the median sits near our normal figure. But the most recent half year is running well below it, and two new acquisitions are unproven. The worst plausible outcome is a multi-year deal drought combined with another bad principal investment. The structure survives that: debt is a single small mortgage, there is no customer concentration of note, and most of the assets are cash and receivables. But equity could shrink further. If we are wrong on the normal level, say $3.5 million rather than $5.6 million, and on the run-off recoveries, say zero, the shares are worth roughly $0.75 to $0.85. Measured against $0.60 a share, the company's normal after-tax cash generation of roughly $0.10 to $0.12 per share is a 17-20% annual yield, and the company has been returning part of it through buybacks ($2.6 million in 2025). Our bear-case value sits slightly above that price. The price assumes normal conditions return within two to three years, in which case the base case points toward the $1.30s; if they do not, the business still covers its debt and keeps generating cash. Above about $0.60 the estimate would depend on the earnings recovery happening on time, so the margin-of-safety price is $0.60.